Changing Incidence of Serum 25-Hydroxyvitamin D Values Above 50 Ng/mL: A 10-Year Population-Based Study

Overview

Journal Mayo Clin Proc

Specialty General Medicine

Date 2015 May 6

PMID 25939935

Citations 45

Authors

Daniel V Dudenkov

Barbara P Yawn

Sara S Oberhelman

Philip R Fischer

Ravinder J Singh

Stephen S Cha

Julie A Maxson

Stephanie M Quigg

Tom D Thacher

Affiliations

Soon will be listed here.

Abstract

Objective: To determine the incidence trend of 25-hydroxyvitamin D (25(OH)D) values above 50 ng/mL and associated toxicity.

Patients And Methods: We conducted a retrospective population-based study in Olmsted County, Minnesota, in the 10-year period from January 1, 2002, through December 31, 2011, by using the Rochester Epidemiology Project. Individuals were eligible if they resided in Olmsted County during the study period and had a measured 25(OH)D value above 50 ng/mL. The date of the first 25(OH)D value above 50 ng/mL was considered the index date for incidence determination. Hypercalcemia, the primary vitamin D toxicity, was considered potentially associated with the 25(OH)D concentration if it was measured within 3 months of the 25(OH)D measurement, and such cases had a medical record review.

Results: Of 20,308 total 25(OH)D measurements, 1714 (8.4%), 123 (0.6%), and 37 (0.2%) unique persons had 25(OH)D values above 50, 80 and above, and 100 ng/mL and above, respectively. The age- and sex-adjusted incidence of 25(OH)D values above 50 ng/mL increased from 9 to 233 cases per 100,000 person-years from 2002 to 2011 (P<.001), respectively, and was greatest in persons aged 65 years and older (P<.001) and in women (P<.001). Serum 25(OH)D values were not significantly related to serum calcium values (P=.20) or with the risk of hypercalcemia (P=.24). A medical record review identified 4 cases (0.2%) in whom 25(OH)D values above 50 ng/mL were temporally associated with hypercalcemia, but only 1 case had clinical toxicity associated with the highest observed 25(OH)D value of 364 ng/mL.

Conclusion: The incidence of 25(OH)D values above 50 ng/mL increased significantly between 2002 and 2011 without a corresponding increase in acute clinical toxicity.

Citing Articles

Vitamin D Deficiency Meets Hill's Criteria for Causation in SARS-CoV-2 Susceptibility, Complications, and Mortality: A Systematic Review.

Wimalawansa S Nutrients. 2025; 17(3).

PMID: 39940457 PMC: 11820523. DOI: 10.3390/nu17030599.

Vitamin D supplementation: Biochemical and inflammatory effects in non-pathological Wistar rats.

Muller de Moura Sarmento S, Gomes Schmitt E, Smolski Dos Santos L, Erminda Schreiner G, Tamborena Malheiros R, Klock C Toxicol Rep. 2025; 14:101901.

PMID: 39897401 PMC: 11786669. DOI: 10.1016/j.toxrep.2025.101901.

Unveiling the Interplay-Vitamin D and ACE-2 Molecular Interactions in Mitigating Complications and Deaths from SARS-CoV-2.

Wimalawansa S Biology (Basel). 2024; 13(10).

PMID: 39452140 PMC: 11504239. DOI: 10.3390/biology13100831.

Physiology of Vitamin D-Focusing on Disease Prevention.

Wimalawansa S Nutrients. 2024; 16(11).

PMID: 38892599 PMC: 11174958. DOI: 10.3390/nu16111666.

Vitamin D Modulates the Response of Patient-Derived Metastatic Melanoma Cells to Anticancer Drugs.

Piotrowska A, Zaucha R, Krol O, Zmijewski M Int J Mol Sci. 2023; 24(9).

PMID: 37175742 PMC: 10178305. DOI: 10.3390/ijms24098037.

References

St Sauver J, Grossardt B, Yawn B, Melton 3rd L, Rocca W . Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester epidemiology project. Am J Epidemiol. 2011; 173(9):1059-68. PMC: 3105274. DOI: 10.1093/aje/kwq482. View

Schwartzman M, Franck W . Vitamin D toxicity complicating the treatment of senile, postmenopausal, and glucocorticoid-induced osteoporosis. Four case reports and a critical commentary on the use of vitamin D in these disorders. Am J Med. 1987; 82(2):224-30. DOI: 10.1016/0002-9343(87)90060-x. View

Vogiatzi M, Jacobson-Dickman E, DeBoer M . Vitamin D supplementation and risk of toxicity in pediatrics: a review of current literature. J Clin Endocrinol Metab. 2014; 99(4):1132-41. DOI: 10.1210/jc.2013-3655. View

Holick M . Vitamin D deficiency. N Engl J Med. 2007; 357(3):266-81. DOI: 10.1056/NEJMra070553. View

Kurland L, Molgaard C . The patient record in epidemiology. Sci Am. 1981; 245(4):54-63. DOI: 10.1038/scientificamerican1081-54. View

Robbins J . ACP Journal Club. Review: high-dose oral vitamin D supplements and active vitamin D prevent falls in older persons. Ann Intern Med. 2010; 152(2):JC1-3. DOI: 10.7326/0003-4819-152-2-201001190-02003. View

Looker A, Pfeiffer C, Lacher D, Schleicher R, Picciano M, Yetley E . Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. Am J Clin Nutr. 2008; 88(6):1519-27. PMC: 2745830. DOI: 10.3945/ajcn.2008.26182. View

Jones G . Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr. 2008; 88(2):582S-586S. DOI: 10.1093/ajcn/88.2.582S. View

Tuohimaa P, Tenkanen L, Ahonen M, Lumme S, Jellum E, Hallmans G . Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries. Int J Cancer. 2003; 108(1):104-8. DOI: 10.1002/ijc.11375. View

10.

Smith H, Anderson F, Raphael H, Maslin P, Crozier S, Cooper C . Effect of annual intramuscular vitamin D on fracture risk in elderly men and women--a population-based, randomized, double-blind, placebo-controlled trial. Rheumatology (Oxford). 2007; 46(12):1852-7. DOI: 10.1093/rheumatology/kem240. View

11.

Chlebowski R, Johnson K, Kooperberg C, Pettinger M, Wactawski-Wende J, Rohan T . Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst. 2008; 100(22):1581-91. PMC: 2673920. DOI: 10.1093/jnci/djn360. View

12.

Durup D, Jorgensen H, Christensen J, Schwarz P, Heegaard A, Lind B . A reverse J-shaped association of all-cause mortality with serum 25-hydroxyvitamin D in general practice: the CopD study. J Clin Endocrinol Metab. 2012; 97(8):2644-52. DOI: 10.1210/jc.2012-1176. View

13.

Ekwaru J, Zwicker J, Holick M, Giovannucci E, Veugelers P . The importance of body weight for the dose response relationship of oral vitamin D supplementation and serum 25-hydroxyvitamin D in healthy volunteers. PLoS One. 2014; 9(11):e111265. PMC: 4220998. DOI: 10.1371/journal.pone.0111265. View

14.

Barger-Lux M, Heaney R . Effects of above average summer sun exposure on serum 25-hydroxyvitamin D and calcium absorption. J Clin Endocrinol Metab. 2002; 87(11):4952-6. DOI: 10.1210/jc.2002-020636. View

15.

Gozdzik A, Barta J, Wu H, Wagner D, Cole D, Vieth R . Low wintertime vitamin D levels in a sample of healthy young adults of diverse ancestry living in the Toronto area: associations with vitamin D intake and skin pigmentation. BMC Public Health. 2008; 8:336. PMC: 2576234. DOI: 10.1186/1471-2458-8-336. View

16.

Koul P, Ahmad S, Ahmad F, Jan R, Shah S, Khan U . Vitamin d toxicity in adults: a case series from an area with endemic hypovitaminosis d. Oman Med J. 2011; 26(3):201-4. PMC: 3191699. DOI: 10.5001/omj.2011.49. View

17.

Pludowski P, Holick M, Pilz S, Wagner C, Hollis B, Grant W . Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence. Autoimmun Rev. 2013; 12(10):976-89. DOI: 10.1016/j.autrev.2013.02.004. View

18.

Holick M, Binkley N, Bischoff-Ferrari H, Gordon C, Hanley D, Heaney R . Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011; 96(7):1911-30. DOI: 10.1210/jc.2011-0385. View

19.

Jacobsen S, Xia Z, Campion M, Darby C, Plevak M, Seltman K . Potential effect of authorization bias on medical record research. Mayo Clin Proc. 1999; 74(4):330-8. DOI: 10.4065/74.4.330. View

20.

Thacher T, Clarke B . Vitamin D insufficiency. Mayo Clin Proc. 2011; 86(1):50-60. PMC: 3012634. DOI: 10.4065/mcp.2010.0567. View